373 related articles for article (PubMed ID: 26195824)
21. APOBEC3B and AID have similar nuclear import mechanisms.
Lackey L; Demorest ZL; Land AM; Hultquist JF; Brown WL; Harris RS
J Mol Biol; 2012 Jun; 419(5):301-14. PubMed ID: 22446380
[TBL] [Abstract][Full Text] [Related]
22. APOBEC3B is preferentially expressed at the G2/M phase of cell cycle.
Hirabayashi S; Shirakawa K; Horisawa Y; Matsumoto T; Matsui H; Yamazaki H; Sarca AD; Kazuma Y; Nomura R; Konishi Y; Takeuchi S; Stanford E; Kawaji H; Murakawa Y; Takaori-Kondo A
Biochem Biophys Res Commun; 2021 Mar; 546():178-184. PubMed ID: 33592502
[TBL] [Abstract][Full Text] [Related]
23. Mesoscale DNA features impact APOBEC3A and APOBEC3B deaminase activity and shape tumor mutational landscapes.
Sanchez A; Ortega P; Sakhtemani R; Manjunath L; Oh S; Bournique E; Becker A; Kim K; Durfee C; Temiz NA; Chen XS; Harris RS; Lawrence MS; Buisson R
Nat Commun; 2024 Mar; 15(1):2370. PubMed ID: 38499542
[TBL] [Abstract][Full Text] [Related]
24. The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1.
McCann JL; Klein MM; Leland EM; Law EK; Brown WL; Salamango DJ; Harris RS
J Biol Chem; 2019 Aug; 294(32):12099-12111. PubMed ID: 31217276
[TBL] [Abstract][Full Text] [Related]
25. Single-Nucleotide Resolution Analysis of 5-Hydroxymethylcytosine in DNA by Enzyme-Mediated Deamination in Combination with Sequencing.
Li QY; Xie NB; Xiong J; Yuan BF; Feng YQ
Anal Chem; 2018 Dec; 90(24):14622-14628. PubMed ID: 30457326
[TBL] [Abstract][Full Text] [Related]
26. Endogenous APOBEC3B Overexpression Constitutively Generates DNA Substitutions and Deletions in Myeloma Cells.
Yamazaki H; Shirakawa K; Matsumoto T; Hirabayashi S; Murakawa Y; Kobayashi M; Sarca AD; Kazuma Y; Matsui H; Maruyama W; Fukuda H; Shirakawa R; Shindo K; Ri M; Iida S; Takaori-Kondo A
Sci Rep; 2019 May; 9(1):7122. PubMed ID: 31073151
[TBL] [Abstract][Full Text] [Related]
27. Ancestral APOBEC3B Nuclear Localization Is Maintained in Humans and Apes and Altered in Most Other Old World Primate Species.
Auerbach AA; Becker JT; Moraes SN; Moghadasi SA; Duda JM; Salamango DJ; Harris RS
mSphere; 2022 Dec; 7(6):e0045122. PubMed ID: 36374108
[TBL] [Abstract][Full Text] [Related]
28. Functional Upregulation of the DNA Cytosine Deaminase APOBEC3B by Polyomaviruses.
Verhalen B; Starrett GJ; Harris RS; Jiang M
J Virol; 2016 Jul; 90(14):6379-6386. PubMed ID: 27147740
[TBL] [Abstract][Full Text] [Related]
29. APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression.
Yamazaki H; Shirakawa K; Matsumoto T; Kazuma Y; Matsui H; Horisawa Y; Stanford E; Sarca AD; Shirakawa R; Shindo K; Takaori-Kondo A
PLoS One; 2020; 15(1):e0223463. PubMed ID: 31914134
[TBL] [Abstract][Full Text] [Related]
30. Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B.
Shi K; Carpenter MA; Banerjee S; Shaban NM; Kurahashi K; Salamango DJ; McCann JL; Starrett GJ; Duffy JV; Demir Ö; Amaro RE; Harki DA; Harris RS; Aihara H
Nat Struct Mol Biol; 2017 Feb; 24(2):131-139. PubMed ID: 27991903
[TBL] [Abstract][Full Text] [Related]
31. The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.
Bogerd HP; Wiegand HL; Doehle BP; Cullen BR
Virology; 2007 Aug; 364(2):486-93. PubMed ID: 17434555
[TBL] [Abstract][Full Text] [Related]
32. Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B.
Shi K; Demir Ö; Carpenter MA; Wagner J; Kurahashi K; Harris RS; Amaro RE; Aihara H
Sci Rep; 2017 Dec; 7(1):17415. PubMed ID: 29234087
[TBL] [Abstract][Full Text] [Related]
33. p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells.
Periyasamy M; Singh AK; Gemma C; Kranjec C; Farzan R; Leach DA; Navaratnam N; Pálinkás HL; Vértessy BG; Fenton TR; Doorbar J; Fuller-Pace F; Meek DW; Coombes RC; Buluwela L; Ali S
Nucleic Acids Res; 2017 Nov; 45(19):11056-11069. PubMed ID: 28977491
[TBL] [Abstract][Full Text] [Related]
34. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.
Law EK; Sieuwerts AM; LaPara K; Leonard B; Starrett GJ; Molan AM; Temiz NA; Vogel RI; Meijer-van Gelder ME; Sweep FC; Span PN; Foekens JA; Martens JW; Yee D; Harris RS
Sci Adv; 2016 Oct; 2(10):e1601737. PubMed ID: 27730215
[TBL] [Abstract][Full Text] [Related]
35. APOBEC3B Nuclear Localization Requires Two Distinct N-Terminal Domain Surfaces.
Salamango DJ; McCann JL; Demir Ö; Brown WL; Amaro RE; Harris RS
J Mol Biol; 2018 Aug; 430(17):2695-2708. PubMed ID: 29787764
[TBL] [Abstract][Full Text] [Related]
36. Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations.
Butt Y; Sakhtemani R; Mohamad-Ramshan R; Lawrence MS; Bhagwat AS
Nat Commun; 2024 Mar; 15(1):2369. PubMed ID: 38499553
[TBL] [Abstract][Full Text] [Related]
37. Small-Angle X-ray Scattering Models of APOBEC3B Catalytic Domain in a Complex with a Single-Stranded DNA Inhibitor.
Barzak FM; Ryan TM; Kvach MV; Kurup HM; Aihara H; Harris RS; Filichev VV; Harjes E; Jameson GB
Viruses; 2021 Feb; 13(2):. PubMed ID: 33673243
[TBL] [Abstract][Full Text] [Related]
38. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of APOBEC3B Recognition Motifs by NMR Reveals Preferred Substrates.
Liu M; Mallinger A; Tortorici M; Newbatt Y; Richards M; Mirza A; van Montfort RLM; Burke R; Blagg J; Kaserer T
ACS Chem Biol; 2018 Sep; 13(9):2427-2432. PubMed ID: 30130388
[TBL] [Abstract][Full Text] [Related]
40. AID enzymatic activity is inversely proportional to the size of cytosine C5 orbital cloud.
Rangam G; Schmitz KM; Cobb AJ; Petersen-Mahrt SK
PLoS One; 2012; 7(8):e43279. PubMed ID: 22916236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
